Cited by 40Psoriasis: Treatment and PathogenesisSkin and Cellular Biology ResearchGenetic and rare skin diseases.

The DOI matches its Crossref record.

Alterations in the desquamation-related proteolytic cleavage of corneodesmosin and other corneodesmosomal proteins in psoriatic lesional epidermis

Simon, M., Tazi-Ahnini, R., Jonca, N., Caubet, C., Cork, M.J., Serre, G.·2008·British Journal of Dermatology

Abstract

BACKGROUND: Desquamation occurs after proteolysis of corneodesmosomal proteins, including corneodesmosin (CDSN), by proteases of the kallikrein family, particularly KLK7. Impaired desquamation is one of the features of psoriasis, and psoriasis-associated single nucleotide polymorphisms of the CDSN gene may potentially modify the proteolysis of the encoded protein. OBJECTIVES: To test whether the proteolysis of CDSN and other corneodesmosomal components is altered in psoriatic epidermis. METHODS: Total protein extracts obtained by tape-stripping of nonlesional and lesional skin from 11 patients were compared by immunoblotting experiments. RESULTS: An almost intact form of CDSN that has never been observed previously in the normal upper stratum corneum was detected in the lesional skin extracts, showing an altered proteolytic processing of the protein. This form was also observed in the nonlesional skin extracts, but in lower amounts. For most patients, increased amounts of desmoglein 1, plakoglobin and of high molecular weight fragments of desmocollin 1 were detected in the lesional skin. For most of them, similar amounts of KLK7 were immunodetected in both nonlesional and lesional skin extracts. No particular differences were observed related to the psoriasis type, the HLA-Cw6 status of the patients or any particular CDSN polymorphisms. CONCLUSIONS: We detected a near full-length form of CDSN that has not been previously observed in normal stratum corneum. The results suggest a reduced degradation of all corneodesmosomal proteins in psoriatic lesions which probably reflects the persistence of corneodesmosomes.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1365-2133.2008.08578.x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Altered corneodesmosomal hydrolysis may disrupt lipid organization and disturb the desquamation process, leading to aberrant barrier function.

    “In SD and dandruff, however, altered corneodesmosomal hydrolysis may disrupt lipid organization and disturb the desquamation process, leading to aberrant barrier function [53,68].”

    From Seborrheic Dermatitis and Dandruff: A Comprehensive Review (2015) · cites this paper as [68]

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 54

  1. Skerrow CJ, 1989, J Cell Sci, 92, 667, 10.1242/jcs.92.4.667 · DOI
  2. 10.1111/1523-1747.ep12492589 · DOI
  3. Kowalczyk AP, 1999, Int Rev Cytol, 185, 237, 10.1016/S0074-7696(08)60153-9 · DOI
  4. 10.1074/jbc.M108438200 · DOI
  5. 10.1074/jbc.M100201200 · DOI
  6. 10.1074/jbc.272.50.31770 · DOI
  7. Egelrud T, 1989, Acta Derm Venereol (Stockh), 69, 470
  8. 10.1111/1523-1747.ep12874531 · DOI
  9. 10.1111/j.1365-2133.1996.tb16230.x · DOI
  10. 10.1007/BF00372058 · DOI
  11. 10.1111/j.0022-202X.2004.22512.x · DOI
  12. 10.1007/BF00371795 · DOI
  13. Long S, 1996, J Invest Dermatol, 106, 872
  14. Rawlings AV, 1994, J Soc Cosmet Chem, 45, 203
  15. 10.1007/BF00373429 · DOI
  16. 10.1046/j.1523-1747.2001.00208.x · DOI
  17. 10.1046/j.1523-1747.2000.00820.x · DOI
  18. Hansson L, 1994, J Biol Chem, 269, 19420, 10.1016/S0021-9258(17)32185-3 · DOI
  19. 10.1111/j.1523-1747.2005.23726.x · DOI
  20. 10.1001/archderm.130.2.216 · DOI
  21. 10.1038/nri1689 · DOI
  22. 10.1046/j.1523-1747.2002.01749.x · DOI
  23. 10.1086/302932 · DOI
  24. 10.1093/hmg/8.12.2165 · DOI
  25. 10.1086/342289 · DOI
  26. 10.1136/jmg.40.6.447 · DOI
  27. 10.1034/j.1399-0039.1999.540501.x · DOI
  28. 10.1034/j.1399-0039.2002.600403.x · DOI
  29. 10.1016/S0140-6736(99)01618-9 · DOI
  30. 10.1093/hmg/9.10.1533 · DOI
  31. 10.1093/hmg/8.6.1135 · DOI
  32. 10.1086/426948 · DOI
  33. 10.1007/s00439-005-0048-2 · DOI
  34. 10.1086/503821 · DOI
  35. Allen M, 2001, Lab Invest, 81, 969, 10.1038/labinvest.3780309 · DOI
  36. 10.1111/j.1365-2133.1997.tb01545.x · DOI
  37. 10.1093/hmg/ddh273 · DOI
  38. 10.1093/hmg/10.17.1793 · DOI
  39. Oestreicher JL, 2001, Pharmacogenomics J, 1, 272, 10.1038/sj.tpj.6500067 · DOI
  40. Zhou X, 2003, Physiol Genomics, 13, 69, 10.1152/physiolgenomics.00157.2002 · DOI
  41. 10.1007/s004410050680 · DOI
  42. 10.1007/s004030050393 · DOI
  43. 10.1111/j.0022-202X.2005.23933.x · DOI
  44. Komatsu N, 2006, J Invest Dermatol, 126, 925
  45. 10.1111/j.0022-202X.2004.23547.x · DOI
  46. 10.1111/j.0022-202X.2004.22331.x · DOI
  47. 10.1111/j.1365-2133.2005.06754.x · DOI
  48. 10.1111/j.1365-2133.2006.07743.x · DOI
  49. 10.1038/75977 · DOI
  50. 10.1111/j.0022-202X.2005.23838.x · DOI
  51. 10.1111/1523-1747.ep12582813 · DOI
  52. 10.2165/00128071-200506040-00002 · DOI
  53. 10.1016/j.febslet.2006.08.039 · DOI
  54. 10.1111/j.1365-2133.1993.tb00138.x · DOI

Cited by

Sorted by citations

Metadata

Authors
Simon, M., Tazi-Ahnini, R., Jonca, N., Caubet, C., Cork, M. J., & Serre, G.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Simon, M.
Venue
British Journal of Dermatology
Published
2008-07
Volume
159
Issue
1
Pages
77-85
ISSN
  • 0007-0963 (ISSN-L)
  • 1365-2133
OpenAlex
W2119629672
Cited by
40
References
0
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2022: 2 · 2021: 3 · 2020: 3 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 1 · 2013: 2 · 2012: 5
FWCI
1.39
Type
journal article
Language
en
Open access
closed
Locations
  • British Journal of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
  • Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
Keywords
corneodesmosin, corneodesmosomes, psoriasis, desquamation, proteolytic processing, kallikrein-kinin system, KLK7, desmoglein 1, plakoglobin, desmocollin 1, stratum corneum, HLA-Cw6
MeSH terms
Adolescent, Adult, Child, Child, Preschool, Desmosomes, Epidermis, Female, Genotype, Glycoproteins, Humans, Immunohistochemistry, Kallikreins, Male, Middle Aged, Psoriasis, Intercellular Signaling Peptides and Proteins, Desmoglein 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review